Assessment of the Efficacy of Withania somnifera Root Extract in Patients with Generalized Anxiety Disorder: A Randomized Double-blind Placebo- Controlled Trial.

Sara FuladiSeyed A EmamiAmir H MohammadpourAsieh KarimaniAli A ManteghiAmirhossein Sahebkar

Published in: Current reviews in clinical and experimental pharmacology (2022)

W. somnifera extract offers some potential advantages as a safe and effective adjunctive therapy to SSRIs in GAD. The clinical trial protocol has been registered under the Iranian Registry of Clinical Trials (IRCT20180615040105N1).

Keyphrases

clinical trial
double blind
placebo controlled
phase ii
study protocol
oxidative stress
phase iii
anti inflammatory
open label
risk assessment
human health